Shanghai Milestone Asset Management Co., Ltd., established in 2007 and headquartered in Shanghai, China, operates as a principal investment firm and hedge fund management company. The firm employs long/short equity strategies and focuses on fundamental, sector-oriented investment approaches that emphasize both value and growth styles. In addition to its hedge fund activities, Milestone engages in private equity, growth, and PIPE investments, primarily targeting sectors such as consumer goods, advanced manufacturing, and medicine.
ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd. develops and commercializes novel cancer immunotherapy products. The company designs platforms to reverse cancer cell-induced immune inhibition and to eradicate cancer cells. It offers platforms harnessing two types of innate immune cells, macrophages and natural killer (NK) cells to fulfill the cancer-killing task. The company’s platforms include Target-Activated NK (TANK™) Cell Therapy, PD-1/PD-L1 antibody blockade assay platform, and Activating Macrophages. The company was founded in 2015 and is headquartered in Shanghai, China.
ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd. develops and commercializes novel cancer immunotherapy products. The company designs platforms to reverse cancer cell-induced immune inhibition and to eradicate cancer cells. It offers platforms harnessing two types of innate immune cells, macrophages and natural killer (NK) cells to fulfill the cancer-killing task. The company’s platforms include Target-Activated NK (TANK™) Cell Therapy, PD-1/PD-L1 antibody blockade assay platform, and Activating Macrophages. The company was founded in 2015 and is headquartered in Shanghai, China.
Cosemitech (Shanghai) Co.,Ltd. manufactures semiconductor chips. Its products include sensor IC including hall switches, gear sensors, linear hall ICs, and current sensors; power management semiconductors such as AC to DC/PFC, LED driver, DC to DC switching regulator, and linear regulator; motor drivers; and automotive system IC including system based chips. The company is based in Shanghai, China.
Seek-Data
Angel Round in 2019
Seek-Data is a smart quantitative investment research company.
ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd. develops and commercializes novel cancer immunotherapy products. The company designs platforms to reverse cancer cell-induced immune inhibition and to eradicate cancer cells. It offers platforms harnessing two types of innate immune cells, macrophages and natural killer (NK) cells to fulfill the cancer-killing task. The company’s platforms include Target-Activated NK (TANK™) Cell Therapy, PD-1/PD-L1 antibody blockade assay platform, and Activating Macrophages. The company was founded in 2015 and is headquartered in Shanghai, China.
Shanghai Ulucu Electronic Technology Co., Ltd. specializes in cloud-based video and network monitoring services, catering to chain enterprises, logistics companies, educational institutions, and government entities. The company offers a comprehensive range of solutions, including research and development, sales, installation, platform operation, and after-sales services for software and hardware. With a robust independent research and development team, Ulucu has made significant advancements in various technologies, such as embedded systems, streaming media transmission, P2P transmission, and cloud server technology, securing multiple national invention patents in the process. Additionally, Ulucu operates a vast national service network, comprising over 300 service stations across all provinces and cities, aimed at providing extensive support to its clients. The company also operates an artificial intelligence platform tailored for new retail environments, which enhances customer interactions through intelligent marketing services, including facial recognition and data analysis to enable personalized shopping experiences.
Developer of autonomous driving systems intended to serve the transportation sector in China. The company's computer vision systems help detect obstacles and oncoming traffic, improving the capabilities of driver-assistance systems.
LenoMed Medical is a medical equipment manufacturer based in Shanghai, China, established in 2014. The company specializes in the development and production of insulin pumps, drug infusion pumps, and related disposables, including the InnoTech insulin pump and infusion sets. With over 15 years of research and development experience in infusion technology, LenoMed is focused on advancing diabetes management through innovative solutions. The company is exploring the integration of continuous glucose monitoring (CGM) technology with insulin pumps to create a closed-loop system, enhancing diabetes care management. LenoMed has formed a strategic alliance with The Pharma Partners to further its objectives in this sector.
Shanghai Ulucu Electronic Technology Co., Ltd. specializes in cloud-based video and network monitoring services, catering to chain enterprises, logistics companies, educational institutions, and government entities. The company offers a comprehensive range of solutions, including research and development, sales, installation, platform operation, and after-sales services for software and hardware. With a robust independent research and development team, Ulucu has made significant advancements in various technologies, such as embedded systems, streaming media transmission, P2P transmission, and cloud server technology, securing multiple national invention patents in the process. Additionally, Ulucu operates a vast national service network, comprising over 300 service stations across all provinces and cities, aimed at providing extensive support to its clients. The company also operates an artificial intelligence platform tailored for new retail environments, which enhances customer interactions through intelligent marketing services, including facial recognition and data analysis to enable personalized shopping experiences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.